DJIA 18,162.99 121.45 0.67%
NASDAQ 5,106.59 73.84 1.47%
S&P 500 2,123.48 19.28 0.92%
market minute promo

239.12 3.81 (1.62%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $239.12 1.62%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $236.00
Previous Close $235.31
Daily Range $234.56 - $239.16
52-Week Range $106.00 - $239.16
Market Cap $81.9B
P/E Ratio 79.77
Dividend (Yield) $0.00 (0.0%)
Volume 2,389,990
Average Daily Volume 1,810,348
Current FY EPS $2.96

Sector

Healthcare

Industry

Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary

Here's What Bill Ackman Has Been Buying and Selling

Bill Ackman's Allergan defeat was kind of a victory.

Synageva BioPharma Files for Kanuma's Approval in Japan - Analyst Blog

3 Drug Stocks Prescribed for Portfolio Growth - Analyst Blog

Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog

Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog

Bristol-Myers' Opdivo Gets Positive Opinion from CHMP - Analyst Blog

Bristol-Myers' Opdivo Gets Positive Opinion from CHMP - Analyst Blog

Novo Nordisk's Saxenda Delays Onset of Type II Diabetes - Analyst Blog

Billionaire George Soros Just Sold These 3 Stocks: Should You?

The Soros Fund Management sold Kite Pharma, Valeant Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. in the first quarter. Should you follow in its footsteps?

Ampio Pharmaceuticals Shoots up on Positive Optina Data - Analyst Blog

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

See More VRX News...

VRX's Top Competitors

VRX $239.12 (1.62%)
Current stock: VRX
JNJ $101.13 (0.31%)
Current stock: JNJ
NVS $103.53 (1.69%)
Current stock: NVS
RHHBY $36.89 (1.81%)
Current stock: RHHBY